Asia’s medicinal cannabis market could cross $5.8 billion by 2024: Report


India is home to the highest number of cannabis consumers in Asia, estimated at 38 million

The Asian medical cannabis market will be worth an estimated $5.8 billion by 2024, the world’s leading market intelligence and strategic consultancy firm Prohibition Partners has found in its latest report. According to analysis, if legislation is introduced in a number of the continent’s major markets, this estimate could quadruple by 2027.

The Asian Cannabis Report, the first detailed report on a fully legalised cannabis industry in Asia, finds that the continent could reap significant rewards through cannabis legalisation. The report includes detailed market value forecasts, regulatory timeline analysis, consumption data and healthcare analyses for seven key markets, including China, India, Thailand and South Korea.

Key findings include:

The Asian cannabis market is expected to be worth $8.5 billion by 2024 if both medical and recreational cannabis are legalised across a number of key

Ga naar Bron